Engineered Antimicrobial Peptides for Resistant Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for novel antimicrobial peptides effective against gram-negative bacteria, which are inherently difficult to treat due to their outer membrane and biofilm-based resistance, and for methods to design and produce such peptides to combat antibiotic-resistant infections.
Innovation Solution
Engineered antimicrobial peptides with specific amino acid sequences, such as FLLKIVALLKKKLL and GVVDIIKGAGKKFAKGLAGKIANKK, are designed using computational approaches like ab initio database filtering technology and positional analysis, combined with bioinformatics prediction, to target both gram-negative and gram-positive bacteria, and are produced through methods involving amino acid frequency calculation and hydrophobicity optimization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antibiotics are used to treat bacterial infections, then antimicrobial activity is achieved, but antibiotic resistance develops and effectiveness decreases
Solution Approach 1:
The patent modifies the structural parameters of antimicrobial peptides by optimizing amino acid sequences, hydrophobicity indices, and charge distributions. These parameter changes enable the peptides to effectively target gram-negative bacteria while avoiding resistance development, as the peptides operate through a different mechanism than traditional antibiotics.
Solution Approach 2:
The patent creates composite antimicrobial peptides that combine multiple functional motifs within a single peptide sequence. These composite structures integrate hydrophobic regions for membrane insertion with cationic regions for electrostatic interaction, achieving broad-spectrum activity against both gram-positive and gram-negative bacteria simultaneously.
2Productivity
If computational methods are used to design antimicrobial peptides, then design efficiency is improved, but validation time and cost increase
Solution Approach 1:
The patent performs comprehensive computational design and prediction before experimental validation. Using machine learning algorithms and in silico modeling, the peptide sequences are optimized for antimicrobial activity and cytotoxicity profiles in advance, reducing the number of experimental iterations needed and accelerating the overall validation process.
Solution Approach 2:
The patent implements iterative feedback loops where experimental results from initial peptide testing are fed back into the computational design algorithm. This feedback mechanism refines the prediction models, allowing for more accurate design-validation cycles and reducing future validation time and resource requirements.
3Measurement precision
If antimicrobial peptides are designed to target gram-negative bacteria, then specificity against resistant strains is improved, but broader spectrum activity may be reduced
Solution Approach 1:
The patent designs antimicrobial peptides with universal structural features that enable them to effectively target multiple bacterial types. By incorporating conserved structural motifs and optimizing the balance between hydrophobicity and charge, the peptides achieve broad-spectrum activity against both gram-positive and gram-negative bacteria, including multi-drug resistant strains.
Solution Approach 2:
The patent introduces local structural variations within the peptide sequence that can be tuned for specific bacterial targets. Certain regions of the peptide contain motif variations that enhance affinity for specific bacterial membrane components, allowing the overall peptide to maintain broad activity while having localized specificity for resistant strains when needed.
Data Source
AI summary
Provided is an engineered antimicrobial peptide. Also provided is a composition comprising an engineered antimicrobial peptide. Provided is a method of treating a subject in need thereof, comprising administering a therapeutically effective amount of a composition comprising an engineered antimicrobial peptide. Also provided is a method of producing an engineered antimicrobial peptide.